Holen Sie sich die Stockscreener-App
55.04
1.10%
-0.66
Crispr Therapeutics Ag Aktie (CRSP) Neueste Nachrichten
CRISPR Therapeutics' General Counsel James R. Kasinger Sells 10,400 Shares Following Option Exercise - Kalkine Media
Form 4 CRISPR Therapeutics AG For: 24 September By Investing.com - Investing.com Nigeria
CRISPR Therapeutics (NASDAQ:CRSP) General Counsel James Kasinger Sells 10,400 Shares of Company Stock - MarketBeat
CRISPR Therapeutics (CRSP) counsel exercised options and sold 10,400 shares under a trading plan. - Stock Titan
CRISPR Therapeutics' Casgevy sales jump 78% in Q2, boosting long-term buy case despite AI gene editing risks - Pluang
Crispr Therapeutics: Why AI Giant Anthropic's Discovery Has Rocked Gene Editing (CRSP) - Seeking Alpha
CRISPR Therapeutics AG (CRSP) stock price, news, quote and history - Yahoo Finance Singapore
CRISPR Therapeutics vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy in 2026? - The Motley Fool
CRISPR Therapeutics AG (CRSP) Stock Price, News, Quote & History - Yahoo! Finance Canada
CRISPR Therapeutics (CRSP) Shares Dip Amid Anthropic AI Enzyme D - gurufocus.com
Gene editing stocks fall after Anthropic’s CRISPR-like discovery - Seeking Alpha
CRISPR Therapeutics AG (CRSP) Options ChainYahoo Finance - Yahoo! Finance Canada
Autologous Hematopoietic Stem Cell Gene Therapy Market - GlobeNewswire
Autologous Hematopoietic Stem Cell Gene Therapy Market Global Report 2026: A $13.44 Billion Market by 2030 as Novartis, Vertex, CRISPR Therapeutics and Orchard Therapeutics Accelerate the Gene-Editing Race - Yahoo Finance UK
What Put the CRISPR Therapeutics (CRSP) Story on the Radar? - Kalkine Media
CRISPR Therapeutics AG (CRSP) Stock Moves 1.20%: What You Should Know - Yahoo Finance
Insider plans $626K CRISPR Therapeutics (NASDAQ: CRSP) stock sale - Stock Titan
symbol__ Stock Quote Price and Forecast - CNN
Ali Behbahani Sells 13,679 Shares of CRISPR Therapeutics (NASDAQ:CRSP) Stock - MarketBeat
CRISPR Therapeutics (CRSP) director exercises options, then sells 13,679 shares around $57 - Stock Titan
Director at CRISPR Therapeutics (CRSP) gets stock in no-cash fund distribution - Stock Titan
Why CRISPR Therapeutics (CRSP) Is Back In The Spotlight - simplywall.st
New Treatment Cuts “Bad” Cholesterol in Half for a Full Year - SciTechDaily
CRISPR Therapeutics stock edges lower as investors digest latest pipeline and earnings figures - AD HOC NEWS
3 Reasons CRISPR Therapeutics Stock Is Still a Buy After a Rocky 2026 - The Motley Fool
CRISPR Therapeutics AG (CRSP) Stock Forecasts - Yahoo Finance
Can Intellia's Pipeline Progress Create Long-Term Value Amid Rivalry? - TradingView
Where Will CRISPR Therapeutics Be in 10 Years if Gene Editing Fulfills Its Promise? - The Motley Fool
CRISPR Therapeutics (NASDAQ:CRSP): What's Behind Its Stock Surge? - Kalkine Media
Director at CRISPR Therapeutics (NASDAQ: CRSP) files notice for six-figure stock sale - Stock Titan
CRISPR Therapeutics (NASDAQ:CRSP) Shares Up 11.6%What's Next? - MarketBeat
CRISPR Therapeutics Surges 11.39% as CRSP Stock Breaks Above $58RSI Oversold Picks - careplusvn.com
Wall Street Analysts Think CRISPR Therapeutics (CRSP) Is a Good Investment: Is It? - Yahoo Finance
CRISPR Therapeutics (CRSP) Stock Looks Above Fair Value On Book Value - simplywall.st
CRISPR Therapeutics AG (CRSP) Sees a More Significant Dip Than Broader Market: Some Facts to Know - Yahoo Finance
CRISPR Therapeutics AG (CRSP) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
CRISPR Therapeutics Eyes CASGEVY Growth, Year-End Pipeline Catalysts - Yahoo Finance
AbbVie vs. CRISPR Therapeutics: Which Healthcare Stock Is a Better Buy in 2026? - Yahoo Finance
CRISPR Therapeutics AG (NASDAQ:CRSP) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
4 Best CRISPR Companies to Buy in 2026 and How to Invest - The Motley Fool
Amgen vs. CRISPR Therapeutics: Which Healthcare Stock Is a Better Buy in 2026? - The Motley Fool
Amgen vs. CRISPR Therapeutics: Which Healthcare Stock Is a Better Buy in 2026? - The Motley Fool
Axsome Therapeutics vs. CRISPR Therapeutics: Which Healthcare Stock Is a Better Buy in 2026? - Yahoo Finance
GOOG: Alphabet IncOrdinary SharesClass C Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits
CRISPR Therapeutics (CRSP) Short Interest & Short Float | Updated Sep 2026 - MarketBeat
Trading Systems Reacting to (CRSP) Volatility - Stock Traders Daily
Why CRISPR Therapeutics Stock Rocked the Market Last Month - The Motley Fool
CRISPR Therapeutics to Present at the Morgan Stanley 24th Annual Global Healthcare Conference - markets.businessinsider.com
Where Will CRISPR Therapeutics Stock Be in 5 Years? - The Motley Fool
Morgan Stanley's healthcare conference will feature CRISPR Therapeutics on Sept. 14 - Stock Titan
Raiffeisen Bank International AG Buys Shares of 20,000 CRISPR Therapeutics AG $CRSP - MarketBeat
0.39%
0.28%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):